Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Here you can browse the complete list of publications for NLST

Studies
Publication Year

Results: 140 (Showing 21 to 40) — Export these results

Title PubMed Id Authors Journal Abbreviation Year Studies
JOURNAL CLUB: Computer-Aided Detection of Lung Nodules on CT With a Computerized Pulmonary Vessel Suppressed Function. 29336601 Lo SB, Freedman MT, Gillis LB, White CS, Mun SK AJR Am J Roentgenol 2018 NLST
Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants. 28050695 Gierada DS, Pinsky PF, Duan F, Garg K, Hart EM, Kazerooni EA, Nath H, Watts JR, Aberle DR Eur Radiol 2017 NLST
Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules. 28439653 Chung K, Jacobs C, Scholten ET, Mets OM, Dekker I, Prokop M, van Ginneken B, Schaefer-Prokop CM Eur Radiol 2017 NLST
Computed tomographic findings in subjects who died from respiratory disease in the National Lung Screening Trial. 28424361 Pompe E, de Jong PA, Lynch DA, Lessmann N, IĆĄgum I, van Ginneken B, Lammers JJ, Mohamed Hoesein FAA Eur. Respir. J. 2017 NLST
Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules? 28339311 Chung K, Jacobs C, Scholten ET, Goo JM, Prosch H, Sverzellati N, Ciompi F, Mets OM, Gerke PK, Prokop M, van Ginneken B, Schaefer-Prokop CM Radiology 2017 NLST
Lung cancer risk in welders and foundry workers with a history of heavy smoking in the USA: The National Lung Screening Trial Jason Y Y Wong, Bryan A Bassig, Wei Jie Seow, Wei Hu, Bu-Tian Ji, Aaron Blair, Debra T Silverman, Qing Lan Occup Environ Med 2017 NLST
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. 27387658 Balekian AA, Tanner NT, Fisher JM, Silvestri GA, Gould MK Ann Am Thorac Soc 2016 NLST
Lung Cancer Deaths in the National Lung Screening Trial Attributed to Nonsolid Nodules. 27378239 Yip R, Yankelevitz DF, Hu M, Li K, Xu DM, Jirapatnakul A, Henschke CI Radiology 2016 NLST
A Bayesian model for estimating multi-state disease progression. 28038345 Shen S, Han SX, Petousis P, Weiss RE, Meng F, Bui AA, Hsu W Comput. Biol. Med. 2016 NLST
Evaluating Long-Term Outcomes via Computed Tomography in Lung Cancer Screening Dongfeng Wu, Ruiqi Liu, Beth Levitt, Tom Riley, Kathy B. Baumgartner J Biom Biostat 2016 NLST
Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. 27009070 Patz EF, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR Lancet Oncol. 2016 NLST
Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): Evidence from The Surveillance, Epidemiology, and End Results Program (SEER) and the National Lung Screening Trial (NLST). 27925181 Goldwasser DL Int. J. Cancer 2016 NLST
Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network. 27664507 Petousis P, Han SX, Aberle D, Bui AA Artif Intell Med 2016 NLST
The Vancouver Lung Cancer Risk Prediction Model: Assessment by Using a Subset of the National Lung Screening Trial Cohort. 27740906 White CS, Dharaiya E, Campbell E, Boroczky L Radiology 2016 NLST
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. 27179989 Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK JAMA 2016 NLST
Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration. 27330355 Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC Curr Oncol 2016 NLST
CANARY Risk Management of Adenocarcinoma: The Future of Imaging? Finbar Foley Srinivasan Rajagopalan Sushravya M. Raghunath Jennifer M. Boland Ronald A. Karwoski Fabien Maldonado Brian J. Bartholmai Tobias Peikert j.semtcsv 2016 NLST
Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial? 27006427 Marcus PM, Doria-Rose VP, Gareen IF, Brewer B, Clingan K, Keating K, Rosenbaum J, Rozjabek HM, Rathmell J, Sicks J, Miller AB Clin Trials 2016 NLST
Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial Barbara L. McComb, Reginald F. Munden, Fenghai Duan, Amanda A. Jain, Catherine Tuite, Caroline Chiles Clin Imaging 2016 NLST
The Potential Clinical, Resource Use, And Fiscal Impacts of Lung-Rads To Inform Lung Cancer Screening In Medicare J. Roth, S.D. Sullivan, S. Ramsey, B. Goulart Val Health 2016 NLST